Cite
MLA Citation
Rosario Pivonello et al.. “Efficacy and safety of osilodrostat in patients with Cushing's disease (LINC 3): a multicentre phase III study with a double-blind, randomised withdrawal phase.” Lancet, vol. 8, no. 9, 2020, pp. 748–761. http://access.bl.uk/ark:/81055/vdc_100106942930.0x00000a